214 related articles for article (PubMed ID: 33585078)
1. The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype.
Thomas PB; Jeffery P; Gahete MD; Whiteside E; Walpole C; Maugham M; Jovanovic L; Gunter J; Williams E; Nelson C; Herington A; Luque RM; Veedu R; Chopin LK; Seim I
PeerJ; 2021; 9():e10280. PubMed ID: 33585078
[TBL] [Abstract][Full Text] [Related]
2. The long non-coding RNA GHSROS facilitates breast cancer cell migration and orthotopic xenograft tumour growth.
Thomas PB; Seim I; Jeffery PL; Gahete MD; Maugham M; Crisp GJ; Stacey A; Shah ET; Walpole C; Whiteside EJ; Nelson CC; Herington AC; Luque RM; Veedu RN; Chopin LK
Int J Oncol; 2019 Dec; 55(6):1223-1236. PubMed ID: 31638176
[TBL] [Abstract][Full Text] [Related]
3. Identification of a long non-coding RNA gene, growth hormone secretagogue receptor opposite strand, which stimulates cell migration in non-small cell lung cancer cell lines.
Whiteside EJ; Seim I; Pauli JP; O'Keeffe AJ; Thomas PB; Carter SL; Walpole CM; Fung JN; Josh P; Herington AC; Chopin LK
Int J Oncol; 2013 Aug; 43(2):566-74. PubMed ID: 23722988
[TBL] [Abstract][Full Text] [Related]
4. The Androgen Regulated lncRNA
Groen L; Yurevych V; Ramu H; Chen J; Steenge L; Boer S; Kuiper R; Smit FP; Verhaegh GW; Mehra N; Schalken JA
Noncoding RNA; 2022 Dec; 8(6):. PubMed ID: 36548180
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA FAM66C is associated with clinical progression and promotes cell proliferation by inhibiting proteasome pathway in prostate cancer.
Xie Y; Gu J; Qin Z; Ren Z; Wang Y; Shi H; Chen B
Cell Biochem Funct; 2020 Dec; 38(8):1006-1016. PubMed ID: 32430927
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.
Fan L; Li H; Wang W
Exp Physiol; 2020 May; 105(5):793-808. PubMed ID: 32086850
[TBL] [Abstract][Full Text] [Related]
7. PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortality.
Bluemn EG; Spencer ES; Mecham B; Gordon RR; Coleman I; Lewinshtein D; Mostaghel E; Zhang X; Annis J; Grandori C; Porter C; Nelson PS
Mol Cancer Res; 2013 Jun; 11(6):568-78. PubMed ID: 23493267
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA (lncRNA) RAMS11 Promotes Metastatis and Cell Growth of Prostate Cancer by CBX4 Complex Binding to Top2α.
Zheng Z; Qiu K; Huang W
Cancer Manag Res; 2021; 13():913-923. PubMed ID: 33564266
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth.
Ta HQ; Whitworth H; Yin Y; Conaway M; Frierson HF; Campbell MJ; Raj GV; Gioeli D
Mol Cancer; 2019 Jun; 18(1):113. PubMed ID: 31253147
[TBL] [Abstract][Full Text] [Related]
10. The long non-coding RNA PCAL7 promotes prostate cancer by strengthening androgen receptor signaling.
Li Z; Teng J; Jia Z; Zhang G; Ai X
J Clin Lab Anal; 2021 Feb; 35(2):e23645. PubMed ID: 33219721
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNAs: From disease code to drug role.
Chen Y; Li Z; Chen X; Zhang S
Acta Pharm Sin B; 2021 Feb; 11(2):340-354. PubMed ID: 33643816
[TBL] [Abstract][Full Text] [Related]
12. Androgen-induced Long Noncoding RNA (lncRNA) SOCS2-AS1 Promotes Cell Growth and Inhibits Apoptosis in Prostate Cancer Cells.
Misawa A; Takayama K; Urano T; Inoue S
J Biol Chem; 2016 Aug; 291(34):17861-80. PubMed ID: 27342777
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis.
Wang J; Yang X; Li R; Wang L; Gu Y; Zhao Y; Huang KH; Cheng T; Yuan Y; Gao S
Oncol Rep; 2018 Nov; 40(5):2814-2825. PubMed ID: 30132573
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA LOC283070 mediates the transition of LNCaP cells into androgen-independent cells possibly via CAMK1D.
Wang L; Lin Y; Meng H; Liu C; Xue J; Zhang Q; Li C; Zhang P; Cui F; Chen W; Jiang A
Am J Transl Res; 2016; 8(12):5219-5234. PubMed ID: 28077997
[TBL] [Abstract][Full Text] [Related]
15. Targeting long non-coding RNAs in cancers: progress and prospects.
Li CH; Chen Y
Int J Biochem Cell Biol; 2013 Aug; 45(8):1895-910. PubMed ID: 23748105
[TBL] [Abstract][Full Text] [Related]
16. The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer.
Malik R; Patel L; Prensner JR; Shi Y; Iyer MK; Subramaniyan S; Carley A; Niknafs YS; Sahu A; Han S; Ma T; Liu M; Asangani IA; Jing X; Cao X; Dhanasekaran SM; Robinson DR; Feng FY; Chinnaiyan AM
Mol Cancer Res; 2014 Aug; 12(8):1081-7. PubMed ID: 25030374
[TBL] [Abstract][Full Text] [Related]
17. Long Non-coding RNA AGAP2-AS1 Silencing Inhibits PDLIM5 Expression Impeding Prostate Cancer Progression
Xie P; Liu M; Chen F; Wu S; Shao T; Wang W; Xu C; Zhou H
Front Genet; 2020; 11():1030. PubMed ID: 33101368
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells.
Yacqub-Usman K; Pickard MR; Williams GT
Prostate; 2015 May; 75(7):693-705. PubMed ID: 25650269
[TBL] [Abstract][Full Text] [Related]
19. SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer.
Zielske SP; Chen W; Ibrahim KG; Cackowski FC
BMC Cancer; 2023 Jul; 23(1):672. PubMed ID: 37464317
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-β1/ Smad signaling pathway.
Zhao B; Lu YL; Yang Y; Hu LB; Bai Y; Li RQ; Zhang GY; Li J; Bi CW; Yang LB; Hu C; Lei YH; Wang QL; Liu ZM
Cancer Biomark; 2018 Feb; 21(3):613-620. PubMed ID: 29278879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
